Who we are

GenCanBio is a virtual drug development company.  Its core executive team has demonstrated expertise in strategic management, drug development and commercialization, R&D project management, intellectual property and financial control. These internal capabilities allow the company to manage contractual collaboration and outsourcing activities with some of the world’s leading government, educational and private research institutions.


What we do

GenCanBio is a Nova Scotia based biotechnology company. We have developed proprietary high-throughput and low-cost in vivo assays to screen plant compounds for a variety of indications. This allows us to quickly and cheaply determine which compounds show bio-activity for specific indications and to take early steps to protect associated intellectual property.


Why we do it

GenCanBio is using its own proprietary in vivo pain and bone regeneration assays to address osteoarthritis, among other indications. The global osteoarthritis market alone is $7 billion and growing 8.5% annually. The two major existing treatments for the long term/chronic pain associated with osteoarthritis are associated with side effects including:

  • NSAIDS–gastrointestinal problems including ulcers
  • Opiates–cardiorespiratory depression and addictio

At GenCanBio we believe we can address the causes as well as the symptoms of osteoarthritis and with minimal or no side effects.